世界のバイオシミラー市場：2010〜2014年

世界におけるバイオシミラー市場は、2010年から2014年かけてCAGR52.2%で拡大すると予測されています。ブランドバイオ医薬品の特許切れが、この成長の主要因のひとつとして挙げられます。

当レポートでは、南北アメリカ、欧州・中東・アフリカ、アジア太平洋地域におけるバイオシミラー市場を調査しており、これらの市場の動向と成長の見通し、主要ベンダーの分析などとともに、概略以下の構成でお届けします。

第1章　エグゼクティブサマリー

第2章　イントロダクション

第3章　市場範囲

第4章　市場情勢

第5章　ベンダー情勢

第6章　購入基準

第7章　市場成長要因

第8章　成長要因とその影響

第9章　市場課題

第10章　市場動向

第11章　主要ベンダーの分析

• Sandoz International GmbH
• Teva Pharmaceutical Industries Ltd.
• Hospira Inc.
• Mylan Inc.

第12章　本シリーズに関連するその他のレポート

図表

ABSTRACT

TechNavio's analysts forecast the Global Biosimilar market to grow at a CAGR of 52.2 percent over the period 2010-2014. One of the key factors contributing to this market growth is the rise in patent expirations of branded biopharmaceuticals. The Global Biosimilar market has also been witnessing the trend of outsourcing of biosimilar manufacturing to Asian countries. However, the risk of drug development failure could pose a challenge to the growth of this market.

TechNavio's report, the Global Biosimilar Market 2010-2014, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Biosimilar market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include Sandoz International GmbH, Teva Pharmaceutical, Industries Ltd., Hospira Inc., and Mylan Inc.

Key questions answered in this report

What will the market size be in 2014 and at what rate will it grow?

What key trends is this market subject to?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the opportunities and threats faced by each of these key vendors?

What are the strengths and weaknesses of each of these key vendors?

TABLE OF CONTENTS

01. Executive Summary

02. Introduction

03. Market Coverage

04. Market Landscape

05. Vendor Landscape

06. Buying Criteria

07. Market Growth Drivers

08. Drivers and their Impact

09. Market Challenges

10. Market Trends

11. Key Vendor Analysis

• 11.1 Sandoz International GmbH
• 11.2 Teva Pharmaceutical Industries Ltd.
• 11.3 Hospira Inc.
• 11.4 Mylan Inc.

12. Other Reports in this Series

List of Exhibits:

• Exhibit 1: Global Biosimilar Market 2010-2014 (US$ million)
• Exhibit 2: Global Biosimilar Market by Geographical Segmentation 2010
• Exhibit 3: Global Biosimilar Market by Vendor Segmentation 2010